Diskussionsleiter: M. Ferrari (Jena), N. Frey (Kiel)
| (P154) | Eine neue Mutation im kardialen Troponin T verursacht eine schwere Form der Noncompaction–Kardiomyopathie. |
|
|
M. Lüdde, P. Ehlermann, D. Weichenhan, R. Will, R. Zeller, S. Rupp, H. Steen, B. Ivandic, A. Müller, M. Kern, H. A. Katus, N. Frey (Kiel, Heidelberg, Gießen) |
| (P155) | Arrhythmien bei Patienten mit Noncompaction Kardiomyopathie – Ergebnisse des ALKK-Noncompaction-Registers |
|
|
B. J. Gerecke, C. Stöllberger, A. Hummel, P. Ong, S. H. Nguyen, R. Engberding (Wolfsburg, Greifswald, Stuttgart, Helmstedt; Wien, AT) |
| (P156) | Longterm Follow Up After Septal Alcohol Ablation Inducing Small Septal Infarctions in Patients With Hypertrophic Obstructive Cardiomyopathy |
|
|
P. Boekstegers, A. Becker, C. Becker, V. Fensterer, H. Küchenhoff, G. Steinbeck (München) |
| (P157) | Segregation of three mutations in a Russian family highlights the importance of exhaustive genetic screening in cardiac hypertrophy |
|
|
S. Waldmüller, K.V. Borisov, J. Davies, J. Haremza, M. Müller, K. Rackebrandt, P. Binner, H.-P. Vosberg, T. Scheffold (Dortmund; Moskau, RU) |
| (P158) | Neurokardiogene Schädigung nach cerebralem Krampfanfall |
|
|
F. Schneider, C. Kadel, M. Pagitz, S. Sen (Frankfurt am Main) |
| (P159) | Neue pathophysiologische Aspekte der kardialen Toxizität von Antidepressiva |
|
|
I. Staudacher, S. Obers, R. Bloehs, E. Ficker, L. Wang, X. Wan, J. Kisselbach, C. Karle, P. Schweizer, R. Becker, H. A. Katus, D. Thomas (Heidelberg; Cleveland, US) |
| (P160) | Remodelling of left ventricular mechanic in dilative cardiomyopathy: A two-dimensional speckle tracking echocardiography study. |
|
|
B. Goebel, K. Meyer, K. Haugaa, S. Otto, C. Jung, A. Lauten, F. Krizanic, T. Edvardsen, H.-R. Figulla, T. Poerner (Jena; Oslo, NO) |
| (P161) | Sequential cardiac protein analysis in anti-beta1 antibody-induced cardiomyopathy reveals endoplasmic reticulum (ER)-stress as a key mediator of increased myocyte apoptosis |
|
|
S. Hartmann, V. Boivin, A. Schlipp, C. Zechmeister, J. Ullrich, V. Schwarzbach, M. Lohse, R. Jahns (Würzburg) |
| (P162) | Evaluation of the cardiac phenotype and the ubiquitin-proteasome system in Lmna∆K32/∆K32 mutant mice |
|
|
S. Maron, A. T. Bertrand, B. Geertz, S. Schlossarek, T. Eschenhagen, G. Bonne, L. Carrier (Hamburg; Paris, FR) |
| (P163) | Gel-free analysis of heart biopsies of patients with inflammatory dilated cardiomyopathy reveals remodelling of mitochondrial pathways and cytoskeletal proteins |
|
|
E. Hammer, M. Goritzka, A. Staudt, S. Ameling, L. Steil, C. Trimpert, L. R. Herda, H. K. Kroemer, K. Klingel, R. Kandolf, S. B. Felix, U. Völker (Greifswald, Tübingen) |
| (P164) | Selective antegrade cerebral perfusion and central aortic cannulation provides superior neurological outcome in acute Type A aortic dissection |
|
|
S. Bauer, K. Bauer, U. Rosendahl, F. Dalladaku, S. Dogan, J. Ennker (Lahr/Baden) |
| (P165) | Comparison of Rivaroxaban, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in vitro study |
|
|
U. Raaz, A. Kaeberich, L. Mägdefessel, T. Linde, U. Steinseifer, E. Perzborn, B. Hauroeder, M. Buerke, K. Werdan, A. Schlitt (Halle/Saale, Aachen, Berlin, Koblenz; Stanford, US) |
| (P166) | Endothelialisation of cardiovascular implants |
|
|
M. Sigler, R. Foth, J. Göbbert, T. Quentin, T. Kriebel, T. Paul (Göttingen) |